NCT03258320: A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis |
|
|
| Recruiting | 1 | 50 | RoW | Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin, Jevtana, Taxotere, Novantrone, JM216. | Shanghai Jiao Tong University School of Medicine, Fudan University, Qilu Hospital of Shandong University | Prostate Cancer Patients | 12/26 | 12/27 | | |